Kbc Group Nv Lannett CO Inc Transaction History

Kbc Group Nv

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 04, 2020	SELL	$6.36 - $10.05 $971,585 - $1.54 Million	-152,765 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$8.49 - $12.81 $519,316 - $783,562	61,168 Added 66.78%	152,765 $1.35 Million
Q1 2019 May 10, 2019	SELL	$5.35 - $9.82 $529,655 - $972,189	-99,001 Reduced 51.94%	91,597 $0
Q4 2018 Jan 31, 2019	SELL	$3.43 - $6.19 $327,352 - $590,761	-95,438 Reduced 33.37%	190,598 $945,000
Q3 2018 Nov 14, 2018	BUY	$4.75 - $14.5 $746,001 - $2.28 Million	157,053 Added 121.76%	286,036 $0
Q2 2018 Aug 03, 2018	SELL	$13.3 - $17.45 $634,277 - $832,190	-47,690 Reduced 26.99%	128,983 $0
Q1 2018 May 09, 2018	BUY	$14.7 - $24.95 $1.89 Million - $3.2 Million	128,375 Added 265.8%	176,673 $0
Q4 2017 Feb 07, 2018	SELL	$19.9 - $29.25 $818,447 - $1.2 Million	-41,128 Reduced 45.99%	48,298 $0
Q3 2017 Nov 13, 2017	BUY	$15.1 - $19.25 $1.35 Million - $1.72 Million	89,426	89,426 $0

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.